Business · 18/10/1996
FDA Approves New Animal Drug for Dogs with Musculoskeletal Inflammation
The FDA is updating its regulations to reflect the approval of a new animal drug, phenylbutazone injection, for use in dogs to alleviate musculoskeletal inflammation, following a supplemental application filed by Phoenix Scientific, Inc.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →